Is INND or MRK a better dividend investment in 2026?

INND currently yields 400000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: INND offers higher current income.

What is the dividend yield difference between INND and MRK?

INND has a forward dividend yield of 400000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 399997.24 percentage points.

Home › Compare › INND vs MRK

INND vs MRK: Dividend Comparison 2026

INND yields 400000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 INND wins by $5.011119029548644e+32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

INND

● Live price

400000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.011119029548644e+32M

Annual income

$500,865,583,351,836,840,000,000,000,000,000,000,000.00

Full INND calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — INND vs MRK

📍 INND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INND	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INND + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INND pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INND

Annual income on $10K today (after 15% tax)

$34,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, INND beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INND + MRK for your $10,000?

INND: 50%MRK: 50%

100% MRK50/50100% INND

Portfolio after 10yr

$2.505559514774322e+32M

Annual income

$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr

Blended yield

99.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

INND

No analyst data

Altman Z

-0.5

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INND buys

MRK buys

No recent congressional trades found for INND or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINNDMRK

Forward yield	400000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$5.011119029548644e+32M	$56.8K ✓
Annual income after 10y	$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$5.010957816668433e+32M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: INND vs MRK ($10,000, DRIP)

Year	INND Portfolio	INND Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$40,010,700	$40,000,000.00	$11,206	$366.19	+$40.00M → INND
2	$149,615,521,729	$149,572,710,280.37	$12,650	$502.35	+$149615.51M → INND
3	$522,880,052,725,200	$522,719,964,116,949.25	$14,407	$694.19	+$522880052.71M → INND
4	$1,707,862,989,289,045,000	$1,707,303,507,632,628,700.00	$16,585	$967.82	+$1707862989289.03M → INND
5	$5,213,509,402,845,684,000,000	$5,211,681,989,447,144,000,000.00	$19,342	$1,363.89	+$5213509402845684.00M → INND
6	$14,874,219,058,409,543,000,000,000	$14,868,640,603,348,497,000,000,000.00	$22,913	$1,947.19	+$14874219058409543680.00M → INND
7	$39,661,196,234,050,755,000,000,000,000	$39,645,280,819,658,260,000,000,000,000.00	$27,662	$2,823.89	+$3.966119623405075e+22M → INND
8	$98,838,436,350,327,300,000,000,000,000,000	$98,795,998,870,356,880,000,000,000,000,000.00	$34,159	$4,173.35	+$9.88384363503273e+25M → INND
9	$230,205,236,474,344,900,000,000,000,000,000,000	$230,099,479,347,450,050,000,000,000,000,000,000.00	$43,337	$6,308.80	+$2.302052364743449e+29M → INND
10	$501,111,902,954,864,400,000,000,000,000,000,000,000	$500,865,583,351,836,840,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$5.011119029548644e+32M → INND

INND vs MRK: Complete Analysis 2026

INND — Stock

InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates 11 audiological and retail hearing device clinics; and offers business to business SaaS based patient management system software program. The company was formerly known as Innerscope Advertising Agency, Inc. and changed its name to InnerScope Hearing Technologies, Inc. in August 2017. InnerScope Hearing Technologies, Inc. was incorporated in 2012 and is headquartered in Roseville, California.

Full INND Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this INND vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INND vs SCHD INND vs JEPI INND vs O INND vs KO INND vs MAIN INND vs JNJ INND vs ABBV INND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.